Maryland lawmakers have approved a bill to extend a psychedelics task force through the end of 2027 to develop updated recommendations on expanding therapeutic access to the novel drugs and potentially creating a regulatory framework for broader legalization.
Days after holding an initial hearing on the legislation from Del. Pam Guzzone (D), members of the House Health Committee voted 18-1 to advance it on Friday. A Senate companion version sponsored by Sen. Brian Feldman (D) was separately taken up in the Finance Committee on Thursday.
Discussion on the House bill was limited, with no amendments or debate.
Both chambers’ proposals are aimed at building upon a current law that created the Maryland Task Force on Responsible Use of Natural Psychedelic Substances.
That panel released an initial final report to state lawmakers last year, with recommendations for the phased implementation of a wide range of reforms to provide legal therapeutic access to substances such as psilocybin.
Members of the task force have already advised that it was ultimately recommending a “multi-pathway framework for safe, broad, and equitable access to natural psychedelic substances, with an initial focus on psilocybin.”
The psychedelics task force was formed following Gov. Wes Moore’s (D) signing
Read full article on Marijuana Moment
